Event Description
Leishmaniasis consists of a complex of vector-borne diseases caused by a heterogeneous group of protozoa belonging to the genus Leishmania; it is transmitted by sand fly vectors. There is a broad array of clinical leishmaniasis syndromes; among these, the clinical course, treatment options, response to therapy, and prognosis are all highly variable. Treatment choices are complicated by the paucity of well-controlled comparative trials and lack of standardized outcome measures.
During this session Dr. Michael Libman, Director, J.D. MacLean Centre for Tropical Diseases at McGill University, Professor of Medicine, Division of Infectious Diseases, Department of Medical Microbiology, will review the clinical spectrum of disease and unravel the complicated treatment options available.
Target Audience
Infectious Disease Community
Speaker(s)
Michael Libman
MD
Continuing Medical Education Credits
In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CREDIT DESIGNATION
Physicians: Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.